Form 144 ARDELYX, INC. Filed by: RAAB MICHAEL

Go back to Form 144 ARDELYX, INC. Filed by: RAAB MICHAEL

Piper Sandler Downgrades Ardelyx, Inc (ARDX) to Neutral, 'Xphozah Outlook Too Uncertain For Us'

July 2, 2024 2:03 PM EDT

Piper Sandler analyst Christopher Raymond downgraded Ardelyx, Inc (NASDAQ: ARDX) from Overweight to Neutral with a price target of $7.00 (from $15.00).

The analyst comments "Downgrade to Neutral. We are stepping to the sidelines on ARDX shares after the surprise revelation that... More